2030 Drug Development Pharmacokinetics 
PPD
APRIL 14, 2025
Food and Drug Administrations (FDA) diversity and inclusion in clinical trials mandate. However, it is representative of the average across most of todays trials, where only 2030% of participants are women. Were applying that expertise and commitment to every aspect of developing and running successful GLP-1 studies.
Drug Target Review
NOVEMBER 15, 2023
Drug discovery is an interdisciplinary process that relies heavily on expert input from diverse and multifaceted teams, from medicinal, synthetic, and computational chemists to biologists and drug metabolism and pharmacokinetics (DMPK) scientists.
DrugBank
MARCH 7, 2024
As we step into 2024, the momentum is expected to continue, with analysts projecting the weight loss drug market to reach remarkable heights, potentially hitting $100 billion by the end of the decade. adults using obesity medications by 2030, further underlining the growing significance of this sector.
Expert insights. Personalized for you.
52 
Let's personalize your content